World-First Human Trial Offers New Type 1 Diabetes Treatment
St Vincent’s Institute of Medical Research
A commonly prescribed rheumatoid arthritis drug may suppress the progression of type 1 diabetes
A commonly prescribed rheumatoid arthritis drug may suppress the progression of type 1 diabetes
Phase 1/2 trial showed the safety and therapeutic potential of administering a novel transgene
Per the WHO records, more than 39 million people were living with HIV at the end of 2022